25 LLC’s Guardant Health GH Stock Holding History

25 LLC’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-37	Closed	-$1.44K	–	221
2023 Q2	$1.44K	Hold	37	–	–	﹤0.01%	235
2023 Q1	$871	Buy	+37	New	+$1.06K	﹤0.01%	243

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

25 LLC's GH Position: Q3 2023 in Review

25 LLC sold out of Guardant Health (GH) in Q3 2023, closing a stake of 37 shares — an estimated $1.44K sold.

25 LLC first reported a position in GH in Q1 2023 and held it in 2 quarters. The position peaked at $1.44K in Q2 2023. 296 funds tracked by Wall St. Rank hold GH as of Q3 2023.

25 LLC reported no remaining Guardant Health position as of Q3 2023 after selling out during the quarter.
25 LLC sold 37 Guardant Health shares in Q3 2023, an estimated $1.44K.
25 LLC first reported a position in Guardant Health in Q1 2023 and held it in 2 quarters.
25 LLC's Guardant Health position peaked at $1.44K in Q2 2023.
296 funds tracked by Wall St. Rank held Guardant Health as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.